Abstract
This review deals with the mechanisms by which the liver disposes of drugs that are covalently or noncovalently associated with proteins. Many drugs bind to plasma proteins such as albumin (mainly anionic compounds) and α1-acid glycoprotein (cationic compounds). Nevertheless, the liver is able to clear such drugs efficiently from the circulation because of intrahepatic dissociation of the drug-protein complex. This clearance may involve spontaneous dissociation because of progressive removal of the unbound drug during liver passage, a process that can be rate limiting in hepatic uptake. Alternatively, the porous endothelial lining of the hepatic sinusoids may allow extensive surface interactions of the drug–protein complexes with hepatocytes, leading to facilitation of drug dissociation. Binding to plasma proteins and intracellular proteins in the cytoplasm or cell organelles is an important factor determining the hepatic storage and elimination rate of drugs. Drugs noncovalently associated with glycosylated proteins, which can be endocytosed by various liver cells, are not co-endocytosed with such proteins. However, covalently bound drugs can be internalized by receptor-mediated endocytosis, which permits specific targeting to hepatocytes, endothelial cells, Kupffer cells, and lipocytes by coupling to different glycoproteins that are recognized on the basis of their terminal sugar. The endocytosed drug–carrier complex is routed into endosomes and lysosomes, where the active drug is liberated by cleavage of acid-sensitive linkages or proteolytic degradation of peptide linkers. This concept has been applied to antineoplastic, antiparasitic, and antiviral drugs.
Similar content being viewed by others
REFERENCES
J. L. Campra and T. B. Reynolds. In I. Arias, H. Popper, D. Schachter, and D. A. Shafritz (eds.), The Liver, Biology and Pathobiology, Raven Press, New York, 1982, pp. 627–645.
A. M. Rappaport, Z. J. Borowy, W. M. Lougheed, and W. N. Lotto. Anat. Rec. 119:11–27 (1954).
R. G. Thurman and F. C. Kauffman. Hepatology (Baltimore) 5:144–151 (1985).
K. Jungerman and N. Katz. Hepatology (Baltimore) 2:385–395 (1982).
J. J. Gumucio. Am. J. Physiol. 244:G578–G582 (1983).
G. M. M. Groothuis, M. J. Hardonk, K. K. Keulemans, P. Nieuwenhuis, and D. K. F. Meijer. Am. J. Physiol. 243:G455–G462 (1982).
I. Braakman, G. M. M. Groothuis, and D. K. F. Meijer. Hepatology 7:849–855 (1987).
E. R. Weibel, W. Staubli, H. R. Gragi, and F. A. Hess. J. Cell. Biol. 42:68–91 (1969).
A. Blouin, R. P. Bolender, and E. R. Weibel. J. Cell Biol. 72:441–455 (1977).
E. Wisse, R. de Zanger, and R. Jacobs. In D. L. Knook and E. Wisse (eds.), Sinusoidal Liver Cells, Elsevier, Amsterdam, 1982, pp. 61–67.
R. de Zanger and E. Wisse. In D. L. Knook and E. Wisse (eds.), Sinusoidal Liver Cells, Elsevier, Amsterdam, 1982, pp. 69–76.
P. Stahl and A. L. Schwartz. J. Clin. Invest. 77:657–662 (1986).
J. L. Goldstein, M. S. Brown, R. G. W. Anderson, D. W. Russell, and W. J. Schneider. Annu. Rev. Cell Biol. 1:1–39 (1985).
C. J. Steer and G. Ashwell. In H. Popper and F. Schaffner (eds.), Progress in Liver Diseases, Vol. 8, Grune and Stratton, New York, 1986, pp. 99–123.
A. L. Schwartz. C.R.C. Crit. Rev. Biochem. 16:207–223 (1984).
T. C. Wileman, C. Harding, and P. Stahl. Biochem. J. 232:1–14 (1985).
G. Ashwell and J. Harford. Annu. Rev. Biochem. 51:531–544 (1982).
H. J. Geuze, J. W. Slot, G. J. A. M. Strous, K. von Figura, A. Hasilik, and A. L. Schwartz. Cell (Cambridge) 37:195–204 (1984).
I. Mellman, R. Fuchs, and A. Helenius. Annu. Rev. Biochem. 55:663–700 (1986).
G. J. Schwartz and Q. Al-Awqati. Annu. Rev. Physiol. 48:153–161 (1986).
F. G. M. Russel, J. G. Weitering, R. Oosting, G. M. M. Groothuis, M. J. Hardonk, and D. K. F. Meijer. Gastroenterology 85:225–234 (1985).
R. R. Townsend, D. A. Wall, A. L. Hubbard, and Y. C. Lee. Proc. Natl. Acad. Sci. USA 81:466–470 (1984).
N. F. La Russo. Am. J. Physiol. 247:G199–G205 (1984).
P. van der Sluijs, I. Braakman, D. K. F. Meijer, and G. M. M. Groothuis. Hepatology 8:1521–1529 (1988).
S. Irie and M. Tavassoli. Biochem. Biophys. Res. Comm. 140:94–100 (1986).
M. Tavassoli, T. Kishimoto, and M. Kataoka. J. Cell Biol. 102:1298–1303 (1986).
T. F. Blaschke. Protein binding and kinetics of drugs in liver disease. Clin. Pharmacokinet. 2:32–44 (1977).
M. Rowland. Clin. Pharmacokin. 9:10–17 (1984).
K. M. Piafsky. Clin. Pharmacokinet. 5:24662 (1980).
Th. N. Tozer. In L. Z. Benet et al. (eds.), Pharmacokinetic Basis for Drug Treatment, Raven Press, New York, 1984, pp. 173–193.
D. K. F. Meijer, C. Neef, and G. M. M. Groothuis. In D. D. Breimer and P. Speiser (eds.), Topics in Pharmaceutical Sciences, Elsevier, Amsterdam, 1983, pp. 167–189.
D. K. F. Meijer. J. Hepatol. 4:259–268 (1987).
P. van der Sluijs and D. K. F. Meijer. J. Pharmacol. Exp. Ther. 234:703–707 (1985).
G. R. Wilkinson and D. G. Shand. Clin. Pharmacol. Ther. 18:377–390 (1975).
D. K. F. Meijer, R. J. Vonk, K. Keulemans, and J. G. Weitering. J. Pharmacol. Exp. Ther. 202:8–21 (1977).
D. K. F. Meijer, A. Blom, J. G. Weitering, and R. Hornsveld. J. Pharmacokinet. Biopharm. 12:43–65 (1984).
H. Grausz and R. Schmid. N. Engl. J. Med. 284:1403–1406 (1971).
M. Inoue. Hepatology (Baltimore) 5:892–898 (1985).
A. Blom, K. Keulemans, and D. K. F. Meijer. Biochem. Pharmacol. 30:1809–1816 (1981).
R. H. Levy and T. A. Moreland. Clin. Pharmacokinet. 9:1–9 (1984).
A. Blom, A. H. J. Scaf, and D. K. F. Meijer. Biochem. Pharmacol. 31:1553–1565 (1982).
E. L. Forker and B. A. Luxon. J. Clin. Invest. 67:1517–1522 (1981).
R. Weisiger, J. Gollan, and R. Ockner. Science 211:1048–1051 (1981).
R. K. Ockner, R. A. Weisiger, and J. L. Gollan. Am. J. Physiol. 245:G13–G18 (1983).
W. E. Muller and U. Wollert. Pharmacology 19:59–67 (1979).
K. J. Baker and S. E. Bradley. J. Clin. Invest. 45:281–287 (1966).
J. R. Bloomer, P. d. Berk, J. Vergalla, and N. I. Berlini. Clin. Sci. Mol. Med. 45:505–516 (1973).
E. L. Forker and B. A. Luxon. Hepatology 5:1236–1237 (1985).
S. C. Tsao, Y. Sugiyama, Y. Sawada, T. Iga, and M. Hanano. J. Pharmacokin. Biopharm. 16:165–181 (1988).
T. Horie, T. Mizuma, S. Kawai, and S. Awazu. Am. J. Physiol. 245:G465–G470 (1988).
W. Stremmel, B. J. Potter, and P. D. Berk. Biochim. Biophys. Acta 756:20–27 (1983).
U. Kragh Hansen. Pharmacol. Rev. 33:17–53 (1981).
D. J. Morgan, D. B. Jones, and R. A. Smallwood. Hepatology 5:1231–1235 (1985).
W. A. Colburn. J. Pharm. Sci. 71:373–374 (1982).
Y. R. Stollman, U. Gartner, L. Theilmann, N. Ohmi, and A. W. Wolkoff. J. Clin. Invest. 72:718–723 (1983).
R. A. Weisiger. Proc. Natl. Acad. Sci. USA 82:1563–1567 (1985).
L. Paul and C. P. Shorma. J. Cell Interface Sci. 84:546–549 (1981).
J. Wilting, W. F. van der Giesen, L. H. Janssen, M. Weideman, M. Otagiri, and J. K. Perrin. J. Biol. Chem. 255:3032–3037 (1980).
R. A. Weisiger and W. L. Ma. J. Clin. Invest. 79:1070–1077 (1987).
G. R. Wilkinson. Pharmacol. Rev. 39:1–47 (1987).
P. van der Sluijs, B. Postema, and D. K. F. Meijer. Hepatology 7:688–695 (1987).
W. B. Karp, M. Kinsley, S. B. Subramanyam, and A. F. Robertson. Alcohol Clin. Exp. Res. 9:429–432 (1985).
A. W. Wolkoff. Hepatology 7:777–779 (1987).
G. M. M. Groothuis, M. J. Hardonk, and D. K. F. Meijer. Trends Pharmacol. Sci. 6:322–327 (1985).
J. L. Barnhart, B. L. Witt, W. Hardison, and R. N. Berk. Am. J. Physiol. 244:G630–G636 (1983).
B. L. Blitzer and L. Lyons. Am. J. Physiol. 249:G34–G38 (1985).
S. Øie and F. Fiori. J. Pharmacol. Exp. Ther. 234:636–640 (1985).
J. H. Anderson, R. C. Anderson, and L. S. Iben. J. Pharmacol. Exp. Ther. 206:172–180 (1978).
M. S. Roberts and M. Rowland. J. Pharmacokinet. Biopharm. 14:261–289 (1986).
R. G. Murray and Y. K. Tam. Drug Metab. Disp. 15:27–31 (1987).
D. L. Eaton and J. A. Richards. Biochem. Pharmacol. 35:2721–2725 (1986).
Y. Echigoya, Y. Matsumoto, Y. Nakagawa, T. Suga, and S. Niinobe. Biochem. Pharmacol. 21:477–484 (1972).
J. W. Edmondson, B. A. Miller, and L. Lumeng. Am. J. Physiol. 249:G427–G433 (1985).
L. R. Engelkind, R. Gronwall, and M. S. Anwer. Am. J. Vet. Res. 41:355–361 (1980).
L. D. de Leve and K. M. Piafsky. Trends Pharmacol. Sci. 2:283–284 (1981).
M. Yashhara, J. Fujiwara, S. Kitade, H. Katayama, K. Okumara, and R. Hori. J. Pharmacol Exp. Ther. 235:513–520 (1985).
J. van Renswoude, K. R. Bridges, J. B. Harford, and R. D. Klausner. Proc. Natl. Acad. Sci. USA 79:6186–6190 (1982).
M. S. Brown and J. L. Goldstein. Science 232:34–47 (1986).
L. Robert, J. Migne, R. Santonja, R. Zini, K. Schmid, and J. P. Tillement. Int. J. Clin. Pharmacol. Ther. Toxicol. 21:271–276 (1983).
H. Karaskova, K. Bezouska, L. Starka, R. Hampl, A. T. Pikulev, M. V. Sholukh, and O. Taborski. J. Steroid Biochem. 24:725–729 (1986).
J. G. Weitering, W. Lammers, D. K. F. Meijer, and G. J. Mulder. Naunyn Schmiedeberg Arch. Pharmacol. 299:277–281 (1977).
Y. Echigoya, Y. Matsumoto, Y. Nakagawa, T. Suga, and S. Niinobe. Biochem. Pharmacol. 21:477–484 (1972).
P. van der Sluijs, H. H. Spanjer, and D. K. F. Meijer. J. Pharmacol. Exp. Ther. 240:668–673 (1987).
B. Ketterer, P. Ross-Mansell, and J. K. Whitehead. Biochem. J. 103:316–324 (1967).
A. J. Levi, Z. Gatmaitan, and I. M. Arias. J. Clin. Invest. 48:2156–2167 (1969).
K. S. Morey and G. Litwack. Biochem. J. 103:316–324 (1967).
C. D. Klaassen and J. B. Watkins. Pharmacol. Rev. 36:1–67 (1984).
N. M. Bass. Chem. Phys. Lipids 38:95–114 (1985).
B. Ketterer, E. Tipping, J. F. Hackney, and D. Beale. Biochem. J. 155:511–521 (1976).
E. L. Forker. Annu. Rev. Physiol. 39:323–347 (1977).
J. A. T. P. Meuwissen, B. Ketterer, and K. P. M. Heirwegh. In P. D. Berk and N. I. Berlin (eds.), Chemistry and Physiology of Bile Pigments, NIH, Bethesda, Md., 1977, pp. 323–327.
A. W. Wolkoff, C. A. Goresky, J. Sellin, Z. Gatmaitan, and I. M. Arias. Am. J. Physiol. 236:E638–E648 (1979).
D. K. F. Meijer, J. G. Weitering, and R. J. Vonk. J. Pharmacol. Exp. Ther. 198:229–239 (1976).
J. G. Weitering, G. J. Mulder, D. K. F. Meijer, W. Lammers, M. Veenhuis, and S. E. Wendelaar-Bonga. Naunyn-Schmiedeberg Arch. Pharmacol. 289:251–256 (1975).
P. Johansson, J. O. Josefsoon, and L. Nassbeyer. Br. J. Pharm. 83:615–623 (1984).
G. J. Kaloyanides. In C. Bianchi, A. Bertelli, and C. G. Duarte (eds.), Kidney, Small Proteins and Drugs, Contributions to Nephrology, Basel, Karger, 1984, pp. 148–167.
R. J. Fallon and A. L. Schwartz. Hepatology (Baltimore) 5:899–901 (1985).
M. J. Poznansky and R. L. Juliano. Pharmacol. Rev. 36:277–336 (1984).
R. A. Firestone, J. M. Pisano, M. M. McPhaul, and M. M. Krieger. J. Med. Chem. 27:1037–1043 (1984).
L. Fiume, A. Mattioli, P. G. Balboni, M. Tognon, B. Brodano, J. de Vries, and Th. Wieland. FEBS Lett. 103:47–51 (1979).
L. Fiume, A. Mattioli, C. Busi, and C. Accorsi. Gut 25:1392–1398 (1984).
J. Hofsteenge, A. Capuano, R. Altszuler, and S. Moore. J. Med. Chem. 29:1765–1769 (1986).
A. Trouet, P. Pirson, R. Baurain, and M. Masquelier. In W. Peters and W. H. G. Richards (eds.), Handbook of Experimental Pharmacology 68, Part 2, Springer Verlag, Berlin, 1984, pp. 253–266.
A. Trouet, M. Masquelier, R. Baurain, and D. Deprez de Campeneere. Proc. Natl. Acad. Sci. USA 79:626–629 (1982).
G. Y. Wu, C. H. Wu, and R. J. Stockert. Proc. Natl. Acad. Sci. USA 80:3078–3080 (1983).
D. L. Simpson, D. B. Cawley, and H. Herschmann. Cell (Cambridge) 29:469–473 (1982).
T. M. Chang and D. W. Killberg. J. Biol. Chem. 257:12563–12572 (1982).
G. Y. Wu, C. H. Wu, and M. I. Rubin. Hepatology (Baltimore) 5:709–713 (1985).
G. Y. Wu and C. H. Wu. Biochemistry 27:887–892 (1988).
L. Fiume, B. Bassi, C. Busi, A. Mattioli, G. Spinosa, and H. Faulstich. FEBS Lett. 203:203–206 (1986).
D. B. Cawley, D. L. Simpson, and H. R. Herschman. Proc. Natl. Acad. Sci. USA 78:3383–3387 (1981).
P. C. Smith and L. Z. Benet. Drug Metab. Disp. 14:503–505 (1986).
P. C. Smith, A. F. McDonagh, and L. Z. Benet. J. Clin. Invest. 77:934–939 (1986).
A. McDonagh, L. A. Palma, J. J. Lauff, and T. W. Wu. J. Clin. Invest. 74:763–764 (1984).
A. Gautam, H. Seligson, E. R. Gordon, D. Seligson, and J. L. Boyer. J. Clin. Invest. 73:873–877 (1984).
T. J. Mauch, T. M. Donohue, R. K. Zetterman, M. Sorrell, and D. J. Tuma. Hepatology (Baltimore) 6:263–269 (1986).
R. C. San George and H. D. Hoberman. J. Biol. Chem. 261:6811–6821 (1986).
H. F. Bunn, K. H. Gabbay, and P. M. Gallop. Science 200:21–27 (1978).
J. W. Baynes, S. R. Thorpe, and M. H. Martiashaw. Meth. Enzymol. 106:88–99 (1984).
N. Iberg and R. Fluckiger. J. Biol. Chem. 261:13542–13545 (1986).
S. Pongor, P. C. Ulrich, F. A. Benisath, and A. Cerami. Proc. Natl. Acad. Sci. USA 81:2684–2688 (1984).
J. L. Witztum, U. P. Steinbrecher, M. Fisher, and A. Kesaniemi. Proc. Natl. Acad. Sci. USA 80:2757–2761 (1983).
V. Vishwanath, K. E. Frank, C. A. Elmets, P. J. Dauchot, and V. M. Monnier. Diabetes 35:916–921 (1986).
V. Monnier, C. A. Elmets, and K. E. Frank. J. Clin. Invest. 78:832–835 (1986).
A. Cerami, H. Vlassara, and M. Brownlee. J. Cell. Biochem. 30:111–120 (1986).
H. Vlassara, M. Brownlee, and A. Cerami. Proc. Natl. Acad. Sci. USA 82:5588–5592 (1985).
H. Vlassara, M. Brownlee, and A. Cerami. J. Exp. Med. 164:1301–1309 (1986).
D. M. Mosser, H. Vlassara, P. J. Edelson, and A. Cerami. J. Exp. Med. 165:140–145 (1987).
J. C. Rogers and S. Kornfield. Biochem. Biophys. Res. Comm. 45:622–629 (1971).
G. Ashwell and C. J. Steer. JAMA 246:2358–2364 (1981).
L. Fiume, B. Bassi, C. Busi, A. Mattioli, and G. Spinosa. Biochem. Pharmacol. 35:967–972 (1986).
D. R. Vera, K. A. Krohn, R. C. Stadalnek, and P. O. Scheibe. Radiology 151:191–156 (1984).
R. C. Stadalnek, D. R. Vera, S. Woodle, W. L. Trudeau, B. A. Porker, R. E. Ward, K. H. Krohn, and L. F. O'Grady. J. Nucl. Med. 26:1233–1242 (1985).
H. J. M. Kempen, C. Hoes, J. H. v. d. Boom, H. H. Spanjer, J. de Lange, and A. Langendoen. J. Med. Chem. 27:1306–1312 (1984).
K. Furuno, N. Miwa, and K. Kabo. J. Biochem. 93:249–256 (1983).
P. van der Sluijs, R. Oosting, J. G. Weitering, M. J. Hardonk, and D. K. F. Meijer. Biochem. Pharmacol. 34:1399–1405 (1985).
S. Bose and J. Hickman. J. Biol. Chem. 252:8336–8337 (1977).
A. Rifai, D. S. Finbloom, D. Magilavy, and P. H. Plotz. J. Immunol. 128:2269–2275 (1982).
R. J. Stockert, H. B. Haimes, A. G. Morell, P. M. Novikoff, A. B. Novikoff, N. Quintana, and J. Sternlieb. Lab. Invest. 43:556–563 (1980).
J. Schmer, J. S. Holcenberg, and J. Roberts. Biochim. Biophys. Acta 538:397–405 (1978).
G. J. Murray, T. W. Doebber, T. Y. Shen, M. S. Wu, M. M. Poupipom, R. L. Bugianesi, R. O. Brady, and J. Barranger. Biochem. Med. 34:241–246 (1985).
F. S. Furbish, C. J. Steer, N. L. Krett, and J. A. Barranger. Biochim. Biophys. Acta 673:425–430 (1981).
V. Keegan-Rogers and G. Y. Wu. Hepatology 7:1026 (1987).
Th. J. C. van Berkel, D. J. Dekker, J. K. Kruyt, and H. G. van Eyk. Biochem. J. 243:715–722 (1987).
A. D. Attie, R. C. Pittman, and D. Steinberg. Proc. Natl. Acad. Sci. USA 77:5923–5927 (1980).
R. Duncan. In J. R. Robinson and V. H. L. Lee (eds.), Controlled Drug Delivery, Marcel Dekker, New York, 1986, pp. 582–607.
D. J. P. FitzGerald, T. A. Waldman, M. C. Willingham, and I. Pastan. J. Clin. Invest. 74:966–971 (1984).
W. C. Shen and H. J. P. Ryser. Biochem. Biophys. Res. Comm. 102:1048–1054 (1981).
E. S. Vitetta and J. W. Uhr. Annu. Rev. Immunol. 3:197–212 (1985).
P. van der Sluijs, H. P. Bootsma, B. Postema, F. Moolenaar, and D. K. F. Meijer. Hepatology 6:723–728 (1986).
L. Fiume, A. Mattioli, C. Busi, G. Spinosa, and Th. Wieland. Experientia 38:1087–1090 (1982).
W. M. Partridge, A. J. van Herle, R. T. Naruse, G. Fierer, and A. Costin. J. Biol. Chem. 258:990–994 (1983).
C. P. Stowell and Y. C. Lee. Adv. Carbohydr. Chem. Biochem. 37:225–281 (1980).
D. R. Vera, K. A. Krohn, R. C. Stadalnik, and P. O. Scheibe. J. Nucl. Med. 25:779–787 (1984).
D. T. Connolly, R. R. Townsend, and K. Kawaguchi. J. Biol. Chem. 257:939–945 (1982).
R. E. Pitas, J. Boyles, and R. W. Mahley. J. Cell Biol. 100:103–117 (1985).
J. F. Nagelkerke, K. P. Barto, and T. J. C. van Berkel. J. Biol. Chem. 258:12221–12227 (1983).
M. S. Brown and J. L. Goldstein. Annu. Rev. Biochem. 52:223–261 (1983).
M. E. Haberland and A. M. Fogelman. Proc. Natl. Acad. Sci. USA 82:2693–2697 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meijer, D.K.F., van der Sluijs, P. Covalent and Noncovalent Protein Binding of Drugs: Implications for Hepatic Clearance, Storage, and Cell-Specific Drug Delivery. Pharm Res 6, 105–118 (1989). https://doi.org/10.1023/A:1015961424122
Issue Date:
DOI: https://doi.org/10.1023/A:1015961424122